APO RESEARCH · REPORT
Pharma & Cosmetics
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.
Product & engineering
Understand the product.
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.
Selected research
Industry Research
Pharma & Cosmetics Industry Research Report 2026
Market perspective
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body's resistance to disease or to help diagnose diseases.
The major players in global Pharma & Cosmetics market include Johnson & Johnson, Roche, Novartis, etc., and the market concentration rate is low. China and Japan are main markets, they occupy about 40% of the global market. Pharmaceuticals, OTC is the main application, which holds a share about 75%.
Report Scope
Read the full market overview
This report quantifies the global Pharma & Cosmetics market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma & Cosmetics Market by Company
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L' OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa
Pharma & Cosmetics Segment by Type
Ointments
Creams
Gels
Others
Pharma & Cosmetics Segment by Application
Pharmaceuticals, OTC
Cosmetics
Pharma & Cosmetics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma & Cosmetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma & Cosmetics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma & Cosmetics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharma & Cosmetics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharma & Cosmetics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharma & Cosmetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Ointments
- Creams
- Gels
- Others
Applications
- Pharmaceuticals, OTC
- Cosmetics
Companies covered
- Johnson & Johnson
- Roche
- Novartis
- Pfizer
- Sanofi
- Eli Lilly
- GSK
- Bayer
- Merck & Co
- L' OREAL
- Unilever
- Procter & Gamble
- Estee Lauder
- Kao
- Shiseido
- Beiersdorf
- Henkel
- Shanghai Jahwa
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharma & Cosmetics Market Size (2021-2032)
- 2.2.2 Global Pharma & Cosmetics Sales (2021-2032)
- 2.2.3 Global Pharma & Cosmetics Market Average Price (2021-2032)
- 2.3 Pharma & Cosmetics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Ointments
- 2.3.3 Creams
- 2.3.4 Gels
- 2.3.5 Others
- 2.4 Pharma & Cosmetics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals, OTC
- 2.4.3 Cosmetics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharma & Cosmetics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharma & Cosmetics Sales (kt) of Manufacturers (2021-2026)
- 3.3 Global Pharma & Cosmetics Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharma & Cosmetics Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharma & Cosmetics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharma & Cosmetics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharma & Cosmetics, Product Type & Application
- 3.8 Global Manufacturers of Pharma & Cosmetics, Established Date
- 3.9 Global Pharma & Cosmetics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Pharma & Cosmetics Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Roche
- 4.2.1 Roche Company Information
- 4.2.2 Roche Business Overview
- 4.2.3 Roche Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Roche Pharma & Cosmetics Product Portfolio
- 4.2.5 Roche Recent Developments
- 4.3 Novartis
- 4.3.1 Novartis Company Information
- 4.3.2 Novartis Business Overview
- 4.3.3 Novartis Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novartis Pharma & Cosmetics Product Portfolio
- 4.3.5 Novartis Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Pharma & Cosmetics Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Sanofi
- 4.5.1 Sanofi Company Information
- 4.5.2 Sanofi Business Overview
- 4.5.3 Sanofi Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi Pharma & Cosmetics Product Portfolio
- 4.5.5 Sanofi Recent Developments
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Company Information
- 4.6.2 Eli Lilly Business Overview
- 4.6.3 Eli Lilly Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eli Lilly Pharma & Cosmetics Product Portfolio
- 4.6.5 Eli Lilly Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Pharma & Cosmetics Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Pharma & Cosmetics Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 Merck & Co
- 4.9.1 Merck & Co Company Information
- 4.9.2 Merck & Co Business Overview
- 4.9.3 Merck & Co Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck & Co Pharma & Cosmetics Product Portfolio
- 4.9.5 Merck & Co Recent Developments
- 4.10 L' OREAL
- 4.10.1 L' OREAL Company Information
- 4.10.2 L' OREAL Business Overview
- 4.10.3 L' OREAL Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 L' OREAL Pharma & Cosmetics Product Portfolio
- 4.10.5 L' OREAL Recent Developments
- 4.11 Unilever
- 4.11.1 Unilever Company Information
- 4.11.2 Unilever Business Overview
- 4.11.3 Unilever Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Unilever Pharma & Cosmetics Product Portfolio
- 4.11.5 Unilever Recent Developments
- 4.12 Procter & Gamble
- 4.12.1 Procter & Gamble Company Information
- 4.12.2 Procter & Gamble Business Overview
- 4.12.3 Procter & Gamble Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Procter & Gamble Pharma & Cosmetics Product Portfolio
- 4.12.5 Procter & Gamble Recent Developments
- 4.13 Estee Lauder
- 4.13.1 Estee Lauder Company Information
- 4.13.2 Estee Lauder Business Overview
- 4.13.3 Estee Lauder Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Estee Lauder Pharma & Cosmetics Product Portfolio
- 4.13.5 Estee Lauder Recent Developments
- 4.14 Kao
- 4.14.1 Kao Company Information
- 4.14.2 Kao Business Overview
- 4.14.3 Kao Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Kao Pharma & Cosmetics Product Portfolio
- 4.14.5 Kao Recent Developments
- 4.15 Shiseido
- 4.15.1 Shiseido Company Information
- 4.15.2 Shiseido Business Overview
- 4.15.3 Shiseido Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Shiseido Pharma & Cosmetics Product Portfolio
- 4.15.5 Shiseido Recent Developments
- 4.16 Beiersdorf
- 4.16.1 Beiersdorf Company Information
- 4.16.2 Beiersdorf Business Overview
- 4.16.3 Beiersdorf Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Beiersdorf Pharma & Cosmetics Product Portfolio
- 4.16.5 Beiersdorf Recent Developments
- 4.17 Henkel
- 4.17.1 Henkel Company Information
- 4.17.2 Henkel Business Overview
- 4.17.3 Henkel Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Henkel Pharma & Cosmetics Product Portfolio
- 4.17.5 Henkel Recent Developments
- 4.18 Shanghai Jahwa
- 4.18.1 Shanghai Jahwa Company Information
- 4.18.2 Shanghai Jahwa Business Overview
- 4.18.3 Shanghai Jahwa Pharma & Cosmetics Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Shanghai Jahwa Pharma & Cosmetics Product Portfolio
- 4.18.5 Shanghai Jahwa Recent Developments
5 Global Pharma & Cosmetics Market Scenario by Region
- 5.1 Global Pharma & Cosmetics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharma & Cosmetics Sales by Region: 2021-2032
- 5.2.1 Global Pharma & Cosmetics Sales by Region: 2021-2026
- 5.2.2 Global Pharma & Cosmetics Sales by Region: 2027-2032
- 5.3 Global Pharma & Cosmetics Revenue by Region: 2021-2032
- 5.3.1 Global Pharma & Cosmetics Revenue by Region: 2021-2026
- 5.3.2 Global Pharma & Cosmetics Revenue by Region: 2027-2032
- 5.4 North America Pharma & Cosmetics Market Facts & Figures by Country
- 5.4.1 North America Pharma & Cosmetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharma & Cosmetics Sales by Country (2021-2032)
- 5.4.3 North America Pharma & Cosmetics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pharma & Cosmetics Market Facts & Figures by Country
- 5.5.1 Europe Pharma & Cosmetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharma & Cosmetics Sales by Country (2021-2032)
- 5.5.3 Europe Pharma & Cosmetics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pharma & Cosmetics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharma & Cosmetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharma & Cosmetics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharma & Cosmetics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharma & Cosmetics Market Facts & Figures by Country
- 5.7.1 South America Pharma & Cosmetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharma & Cosmetics Sales by Country (2021-2032)
- 5.7.3 South America Pharma & Cosmetics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pharma & Cosmetics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharma & Cosmetics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharma & Cosmetics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharma & Cosmetics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pharma & Cosmetics Sales by Type (2021-2032)
- 6.1.1 Global Pharma & Cosmetics Sales by Type (2021-2032) & (kt)
- 6.1.2 Global Pharma & Cosmetics Sales Market Share by Type (2021-2032)
- 6.2 Global Pharma & Cosmetics Revenue by Type (2021-2032)
- 6.2.1 Global Pharma & Cosmetics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharma & Cosmetics Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharma & Cosmetics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharma & Cosmetics Sales by Application (2021-2032)
- 7.1.1 Global Pharma & Cosmetics Sales by Application (2021-2032) & (kt)
- 7.1.2 Global Pharma & Cosmetics Sales Market Share by Application (2021-2032)
- 7.2 Global Pharma & Cosmetics Revenue by Application (2021-2032)
- 7.2.1 Global Pharma & Cosmetics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharma & Cosmetics Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharma & Cosmetics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharma & Cosmetics Value Chain Analysis
- 8.1.1 Pharma & Cosmetics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharma & Cosmetics Production Mode & Process
- 8.2 Pharma & Cosmetics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharma & Cosmetics Distributors
- 8.2.3 Pharma & Cosmetics Customers
9 Global Pharma & Cosmetics Analyzing Market Dynamics
- 9.1 Pharma & Cosmetics Industry Trends
- 9.2 Pharma & Cosmetics Industry Drivers
- 9.3 Pharma & Cosmetics Industry Opportunities and Challenges
- 9.4 Pharma & Cosmetics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst